Discussing Approaches to Enhance Clinical Study Diversity Public Workshop

On November 29 and 30, 2023, FDA in collaboration with the Clinical Trials Transformation Initiative will host a virtual public workshop to solicit input on increasing the enrollment of historically underrepresented populations in clinical studies and encouraging clinical study participation that reflects the prevalence of the disease or condition among demographic subgroups.

The public workshop will take place from 10 a.m. to 2 p.m. ET on both days and is free to attend.